Philips reports 2% growth in adjusted sales:
This article was originally published in Clinica
Sales of Philips medical systems contributed to the 2% growth of adjusted turnover reported for Professional Products and Systems in the first half of the year. Sales in this division were Fl 3,566 million ($2,300 million), down 2% from last year nominally. However, adjusted for exchange rate movements and consolidation, sales were 2% higher. The division's operational loss rose to Fl 103 million in the first half compared with Fl 61 million a year earlier. Philips' group sales rose 5% to Fl 29,278 million and net income rose to Fl 1,327 million from Fl 662 million last year.
You may also be interested in...
Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.
Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.
At the OurCrowd Global Investor Summit in Jerusalem, Israel, on 13 February, Medtech Insight met wound care device company Nanomedic to find out more about its unique electro-spinning technology.